Comparison of different technologies for producing recombinant adeno-associated virus on a laboratory scale
Adeno-associated virus vectors are among the most promising ones for the delivery of transgenes to various organs and tissues. Recombinant adeno-associated virus (rAAV) is able to transduce both dividing and non-dividing cells, has low immunogenicity, and is able to provide long-term expression of t...
Main Authors: | E. I. Ryabova, A. A. Derkaev, I. B. Esmagambetov, D. V. Shcheblyakov, M. A. Dovgiy, D. V. Byrikhina, V. V. Prokofiev, I. P. Chemodanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2021-12-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/354 |
Similar Items
-
An Efficient Method for Isolation of Plasmid DNA for Transfection of Mammalian Cell Cultures
by: Daniel V. Kachkin, et al.
Published: (2020-10-01) -
Development of recombinant adeno-associated virus empty capsids as a reference standard for quality control of gene therapy products
by: A. V. Tumaev, et al.
Published: (2024-07-01) -
High-Level Expression of Palmitoylated MPP1 Recombinant Protein in Mammalian Cells
by: Agnieszka Chytła, et al.
Published: (2021-09-01) -
Impact of lipopolysaccharides on cultivation and recombinant protein expression in human embryonal kidney (HEK‐293) cells
by: Christine Faust, et al.
Published: (2021-11-01) -
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS
by: Metehan Ilter, et al.
Published: (2022-12-01)